Harold Eugene Brakewood insider trades: Immuneering (IMRX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Harold reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 16, 2026 | IMRX | ↑ Buy | 5,250 | $4.76 | $25K | Direct | Jan 21, 2026 (5d) |
| Jun 20, 2025 | IMRX | ↑ Buy | 1,900 | $2.53 | $5K | Direct | Jun 24, 2025 (4d) |
| Mar 22, 2024 | IMRX | ↑ Buy | 3,900 | $2.57 | $10K | Direct | Mar 25, 2024 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IMRX insiders
Open-market trades in the last 12 months
About Harold Eugene Brakewood's insider trades
Harold Eugene Brakewood is Chief Business Officer at Immuneering (IMRX). Since Mar 22, 2024, Harold has reported 3 open-market purchases worth $40K and no sales on SEC Form 4. In the last 12 months: 1 buy ($25K).
Their filings also include grants and awards (5 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.